Largest biotech by total liabilities

Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.

Amgen leads the 24 biotech ranked by total liabilities, at NOK 793.7B, ahead of Gilead Sciences (NOK 352.7B) and Biogen (NOK 108.3B). Figures as of 18 Nov 2026, 14:30 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
AmgenNOK 793.7B
Median
NOK 6.8B
Combined market value
NOK 8.21T
Countries
5

Market values as of .

Largest biotech by total liabilities
#CompanyTotal liabilities ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareNOK 793.7BNOK 2.38TNOK 4,393.77 0.96% down 34% up United States
2Gilead SciencesGILD · Health CareNOK 352.7BNOK 2.05TNOK 1,649.49 1.60% up 33% up United States
3BiogenBIIB · Health CareNOK 108.3BNOK 359.2BNOK 2,429.67 0.34% down 49% up United States
4ModernaMRNA · Health CareNOK 35.7BNOK 815.4BNOK 2,015.11 0.58% up 755% up United States
5BioNTechBNTX · Health CareNOK 29.7BNOK 203.8BNOK 822.13 0.47% down 16% down Germany
6QiagenQGEN · Health CareNOK 24.2BNOK 99.4BNOK 481.30 0.14% down 12% up Netherlands
7Halozyme TherapeuticsHALO · Health CareNOK 24BNOK 106BNOK 929.76 0.55% down 37% up United States
8Neurocrine BiosciencesNBIX · Health CareNOK 13.4BNOK 162.7BNOK 1,607.44 0.37% up 20% up United States
9argenxARGX · Health CareNOK 13.2BNOK 577.3BNOK 9,179.62 0.36% down 4% up Belgium
10ImmunityBioIBRX · Health CareNOK 9.7BNOK 64.4BNOK 60.53 0.20% down 193% up United States
11RepligenRGEN · Health CareNOK 8.2BNOK 100.4BNOK 1,571.21 0.37% down 5% up United States
12Revolution MedicinesRVMD · Health CareNOK 7BNOK 340.9BNOK 1,576.15 2.50% down 131% up United States
13ExelixisEXEL · Health CareNOK 6.6BNOK 160.9BNOK 659.56 0.61% down 63% up United States
14Bio-TechneTECH · Health CareNOK 4.6BNOK 110.5BNOK 703.64 0.22% down 26% up United States
15CRISPR TherapeuticsCRSP · Health CareNOK 3.3BNOK 37.7BNOK 388.98 0.54% down 21% down Switzerland
16VaxcytePCVX · Health CareNOK 3.1BNOK 91.1BNOK 575.47 3.59% down 22% up United States
17Adaptive BiotechnologiesADPT · Health CareNOK 2.8BNOK 43.3BNOK 267.58 3.05% down 88% up United States
18Kodiak SciencesKOD · Health CareNOK 1.9BNOK 61.3BNOK 937.80 3.90% down 396% up United States
19Twist BioscienceTWST · Health CareNOK 1.6BNOK 74BNOK 1,085.06 6.63% up 340% up United States
20Kymera TherapeuticsKYMR · Health CareNOK 1.6BNOK 100.5BNOK 1,177.29 3.44% down 87% up United States
21Scholar Rock HoldingSRRK · Health CareNOK 1.5BNOK 53.3BNOK 436.74 1.21% up 14% up United States
22Krystal BiotechKRYS · Health CareNOK 1.1BNOK 85.4BNOK 2,883.16 0.32% down 46% up United States
23ImmunovantIMVT · Health CareNOK 1BNOK 66.6BNOK 321.74 0.21% down 43% up United States
24CG OncologyCGON · Health CareNOK 377.7MNOK 68.3BNOK 764.77 6.89% down 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 9.6881 NOK).

Questions and answers

Which biotech rank first by total liabilities?

Amgen (NOK 793.7B), Gilead Sciences (NOK 352.7B) and Biogen (NOK 108.3B) are the top three of the 24 biotech ranked by total liabilities as of 18 Nov 2026, 14:30 UTC.

How many biotech are in this ranking?

24 are ranked by total liabilities.

What are these biotech worth together?

The 24 biotech ranked by total liabilities have a combined market value of NOK 8.21T as of 18 Nov 2026, 14:30 UTC.

What does ranking by total liabilities measure?

Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.

Cite this page

Funkfolio, “Largest biotech by total liabilities”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=total-liabilities

Underlying data: Yahoo Finance; SEC EDGAR.